Mandate

Vinge advises EQT Infrastructure II fund on the acquisition of Hector Rail

September 16, 2014

Vinge advises EQT Infrastructure II fund in connection with the acquisition of a majority stake in Hector Rail AB, a leading Sweden-based independent rail freight company, from investment entities advised by Höegh Capital Partners, the founders Mats Nyblom and Ole Kjörrefjord, and other minority owners. Hector Rail was founded in 2004, supported by the Norwegian Høegh family. The Company, headquartered in Stockholm, Sweden, has around 190 employees operating in Sweden, Norway, Denmark and Germany.

Hector Rail offers environmentally friendly transportation services of heavy industry products, raw materials, intermodal freight and passengers to clients such as industrial companies, forwarders, and other rail companies under medium term contracts. The Company currently operates a fleet of around 50 locomotives and 10 shunters performing over 6 million train kilometres per year. Revenues amounted to approximately SEK 630 million in 2013.

Vinge’s team consisted of responsible partner Daniel Rosvall together with, amongst others, project manager Matthias Pannier and associate Maria Dahlin (all corporate).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025